4.6 Article

Functional and physical interactions of the herpes simplex virus type 1 UL20 membrane protein with glycoprotein K

期刊

JOURNAL OF VIROLOGY
卷 82, 期 13, 页码 6310-6323

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.00147-08

关键词

-

类别

资金

  1. NIAID NIH HHS [R01 AI043000, AI43000] Funding Source: Medline

向作者/读者索取更多资源

Herpes simplex virus type 1 glycoprotein K (gK) and the UL20 protein (UL20p) are coordinately transported to the trans-Golgi network (TGN) and cell surfaces and are required for cytoplasmic virion envelopment at the TGN. In addition, cell surface expression of gK and UL20p is required for virus-induced cell fusion. Previously, confocal microscopy colocalization and intracellular transport experiments strongly suggested direct protein-protein interactions between gK and UL20p. Direct protein-protein interactions between gK and UL20p were demonstrated through reciprocal coimmunoprecipitation experiments, as well as with glutathione S-transferase (GST) pull-down experiments. A fusion protein consisting of the amino-terminal 66 amino acids of UL20p fused in-frame with GST was expressed in Escherichia coli and purified via glutathione column chromatography. Precipitation of GST-UL20p from mixtures of GST-UL20p fusion protein with cellular extracts containing gK specifically coprecipitated gK but not other viral glycoproteins. The purified UL20p-GST fusion protein reacted with all gK-associated protein species. It was concluded that the amino terminus of UL20p, most likely, interacted with gK domain III, which is predicted to lie intracellularly. UL20p-gK domain-specific interactions must serve important functions in the coordinate transport of UL20p and gK to the TGN, because retention of UL20p in the endoplasmic reticulum (ER) via the addition of an ER retention signal at the carboxyl terminus of UL20p forced the ER retention of gK and drastically inhibited intracellular virion envelopment and virus-induced cell fusion.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes

David Bernstein, Derek A. Pullum, Rhonda D. Cardin, Fernando J. Bravo, David A. Dixon, Konstantin G. Kousoulas

VACCINE (2019)

Article Veterinary Sciences

Factors Affecting Growth Kinetics and Spontaneous Metastasis in the B16F10 Syngeneic Murine Melanoma Model

Natalie Fowlkes, Kelli Clemons, Paul J. F. Rider, Ramesh Subramanian, Nobuko Wakamatsu, Ingeborg Langohr, Konstantin G. Kousoulas

COMPARATIVE MEDICINE (2019)

Article Multidisciplinary Sciences

Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials

David I. Bernstein, Rhonda D. Cardin, Derek A. Pullum, Fernando J. Bravo, Konstantin G. Kousoulas, David A. Dixon

PLOS ONE (2019)

Article Cell Biology

Fisetin, a 3,7,3′,4′-Tetrahydroxyflavone Inhibits the PI3K/Akt/mTOR and MAPK Pathways and Ameliorates Psoriasis Pathology in 2D and 3D Organotypic Human Inflammatory Skin Models

Jean Christopher Chamcheu, Stephane Esnault, Vagar M. Adhami, Andrea L. Noll, Sergette Banang-Mbeumi, Tithi Roy, Sitanshu S. Singh, Shile Huang, Konstantin G. Kousoulas, Hasan Mukhtar

Article Genetics & Heredity

Genomic analysis for virulence determinants in feline herpesvirus type-1 isolates

Andrew C. Lewin, Lyndon M. Coghill, Gillian J. McLellan, Ellison Bentley, Konstantin G. Kousoulas

VIRUS GENES (2020)

Article Multidisciplinary Sciences

Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1 (F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesis

Shan K. Naidu, Rafiq Nabi, Nagarjuna R. Cheemarla, Brent A. Stanfield, Paul J. Rider, Nithya Jambunathan, Vladimir N. Chouljenko, Renee Carter, Fabio Del Piero, Ingeborg Langohr, Konstantin G. Kousoulas

PLOS ONE (2020)

Article Virology

The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections

Farhana Musarrat, Vladimir Chouljenko, Achyut Dahal, Rafiq Nabi, Tamara Chouljenko, Seetharama D. Jois, Konstantin G. Kousoulas

JOURNAL OF MEDICAL VIROLOGY (2020)

Article Virology

Cellular and Viral Determinants of Herpes Simplex Virus 1 Entry and Intracellular Transport toward the Nuclei of Infected Cells

Farhana Musarrat, Vladimir Chouljenko, Konstantin G. Kousoulas

Summary: Herpes simplex virus 1 utilizes cellular motor proteins and kinase pathways for intracellular virion transport, with Akt and kinase C inhibitors blocking virus entry and virion capsid transport. UL37 and Vp5 viral proteins are crucial for dynein-dependent transport of virion capsids, while Akt and kinase C do not directly phosphorylate or activate dynein during infection.

JOURNAL OF VIROLOGY (2021)

Article Biochemistry & Molecular Biology

Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers

Tithi Roy, Samuel T. Boateng, Sergette Banang-Mbeumi, Pankaj K. Singh, Pratik Basnet, Roxane-Cherille N. Chamcheu, Federico Ladu, Isabel Chauvin, Vladimir S. Spiegelman, Ronald A. Hill, Konstantin G. Kousoulas, Bolni Marius Nagalo, Anthony L. Walker, Jean Fotie, Siva Murru, Mario Sechi, Jean Christopher Chamcheu

Summary: Novel flavonol-based derivatives targeting skin cancers were synthesized and characterized, showing significant inhibitory effects on human skin cancer cell lines. These compounds were found to induce apoptosis of cancer cells by regulating key molecular targets, presenting promising therapeutic potential for melanoma and non-melanoma skin cancers.

BIOORGANIC CHEMISTRY (2021)

Article Virology

Development of a reliable bovine neuronal cell culture system and labeled recombinant bovine herpesvirus type-1 for studying virus-host cell interactions

Jared S. Rudd, Farhana Musarrat, Konstantin G. Kousoulas

Summary: BoHV-1 infects bovine-derived neuronal cells and can be efficiently studied using FBBC-1 cells. The study provides insights into virus entry and spread mechanisms in a neuronal cell culture system.

VIRUS RESEARCH (2021)

Review Virology

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment

Ifeanyi Kingsley Uche, Konstantin G. Kousoulas, Paul J. F. Rider

Summary: The development of cancer disrupts anti-tumor immunity needed for surveillance and elimination of tumor cells, with immunotherapy aiming to restore or establish these responses. However, a significant proportion of patients do not respond equally to immunotherapies, partially due to the immunosuppressive tumor microenvironment. Current research focuses on mechanisms of immunosuppression in the TME, with the goal of promoting anti-tumor immune responses.

VIRUSES-BASEL (2021)

Article Multidisciplinary Sciences

Identification of new fisetin analogs as kinase inhibitors: Data on synthesis and anti-skin cancer activities evaluation

Tithi Roy, Samuel T. Boateng, Sergette Banang-Mbeumi, Pankaj K. Singh, Pratik Basnet, Roxane-Cherille N. Chamcheu, Federico Ladu, Isabel Chauvin, Vladimir S. Spiegelman, Ronald A. Hill, Konstantin G. Kousoulas, Bolni Marius Nagalo, Anthony L. Walker, Jean Fotie, Siva Murru, Mario Sechi, Jean Christopher Chamcheu

Summary: This study identifies a panel of novel fisetin analogs that may be developed as potential therapeutic agents for melanoma and non-melanoma skin cancers, providing in-depth biological characterization data to support further research and experimental screening.

DATA IN BRIEF (2021)

Article Virology

Novel Oncolytic Herpes Simplex Virus 1 VC2 Promotes Long-Lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-Derived Mouse Melanoma Model

Ifeanyi Kingsley Uche, Natalie Fowlkes, Luan Vu, Tatiane Watanabe, Mariano Carossino, Rafiq Nabi, Fabio del Piero, Jared S. Rudd, Konstantin G. Kousoulas, Paul J. F. Rider

Summary: Oncolytic virotherapy (OVT) uses viral infection to release tumor antigens, promoting antitumor immune responses. VC2, a modified herpes simplex virus, shows clinical potential in a mouse melanoma model and may be an effective treatment for human and animal cancers.

JOURNAL OF VIROLOGY (2021)

Article Microbiology

Anti-viral Immunity in the Tumor Microenvironment: Implications for the Rational Design of Herpes Simplex Virus Type 1 Oncolytic Virotherapy

Paul J. F. Rider, Ifeanyi K. Uche, Larissa Sweeny, Konstantin G. Kousoulas

CURRENT CLINICAL MICROBIOLOGY REPORTS (2019)

暂无数据